SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 10, 2004
IntraBiotics Pharmaceuticals, Inc.
| Delaware | 0-29993 | 94-3200380 | ||
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) | ||
2483 East Bayshore Road, Suite 100
Palo Alto, California 94303
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (650) 526-6800
| Not Applicable |
| (Former name or former address, if changed since last report.) |
| Item 12. Results of Operations and Financial Condition. | ||||||||
| SIGNATURE | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 12. Results of Operations and Financial Condition.
On May 10, 2004, IntraBiotics Pharmaceuticals, Inc. reported its results of operations for its fiscal first quarter ended March 31, 2004. A copy of the press release issued by the Registrant, entitled “IntraBiotics Reports First Quarter 2004 Financial and Operating Results,” concerning the foregoing results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
The information contained in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| INTRABIOTICS PHARMACEUTICALS, INC. | ||
Date: May 12, 2004 |
||
| /s/ David Tucker | ||
| David Tucker | ||
| Principal Financial Officer |